Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1093/femspd/ftaa025

http://scihub22266oqcxt.onion/10.1093/femspd/ftaa025
suck pdf from google scholar
32510562!7314002!32510562
unlimited free pdf from europmc32510562    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32510562  :  Publisher

suck abstract from ncbi

pmid32510562
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge #MMPMID32510562
  • Papachristodoulou E; Kakoullis L; Parperis K; Panos G
  • Pathog Dis 2020[Apr]; 78 (3): ä PMID32510562show ga
  • Effective herd immunity against SARS-CoV-2 will be determined on many factors: the percentage of the immune population, the length and effectiveness of the immune response and the stability of the viral epitopes. The required percentage of immune individuals has been estimated to be 50-66% of the population which, given the current infection rates, will take long to be achieved. Furthermore, data from SARS-CoV suggest that the duration of immunity may not be sufficiently significant, while the immunity response against SARS-CoV-2 may not be efficiently effective in all patients, as relapses have already been reported. In addition, the development of mutant strains, which has already been documented, can cause the reemergence of the epidemic. In conclusion, the development of an effective vaccine is an urgent necessity, as long-term natural immunity to SARS-CoV-2 may not be sufficient for the control of the current and future outbreaks.
  • |*Immunity, Herd[MESH]
  • |Betacoronavirus/*immunology[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/epidemiology/*immunology/*virology[MESH]
  • |Humans[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/epidemiology/*immunology/*virology[MESH]
  • |SARS-CoV-2[MESH]
  • |Time Factors[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    ä 3.78 2020